Exciting Autism Research: Hopeful Breakthroughs for Rett and Dravet Syndromes! | #autism #news #parenting #rett syndrome #dravet syndrome #research #treatment
Exciting Autism Research: Hopeful Breakthroughs for Rett and Dravet Syndromes! | #autism #news #parenting #rett syndrome #dravet syndrome #research #treatment
brindha
For Rett syndrome, Trofinetide (Daybue) is the first FDA-approved treatment, improving behavior, communication, mood, breathing, and hand movements. Researchers are also looking into gene replacement therapies as potential cures.
In Dravet syndrome, gene replacement therapy targeting SCN1A has shown promise in mouse models. TAU depletion has also been effective in reducing seizures and improving survival. Zorevunersen has demonstrated sustained seizure reductions and improvements in behavior and cognition in patients. You can find more information on the Emperor study [https://www.emperorstudy.com/].
মন্তব্য মুছুন
আপনি কি এই মন্তব্যটি মুছে ফেলার বিষয়ে নিশ্চিত?